Vol 8, Issue 3
Pages 738–742
Published: 07 Aug 2025
Tasnuva Ashraf*,1, Ayesha Siddika2, Papia Heven3, Humaira Afreen4, Dilruba Aktar5
Article Information
Citation: Tasnuva Ashraf, Ayesha Siddika, Papia Heven, Humaira Afreen, Dilruba Aktar. Evaluation of Beta-Blockers as Triggers for Drug-Induced Lichen Planus in Hypertensive Patients. Fortune Journal of Health Sciences. 8 (2025): 738-742.
DOI: 10.26502/fjhs.331
Share
Abstract
Introduction: Lichen planus (LP) is a chronic inflammatory skin condition that can also affect mucosal surfaces, presenting as a variety of forms including oral, cutaneous, genital, and mixed types. The exact cause of LP remains unclear, but it is often associated with immune system dysfunction, genetic predisposition, and environmental triggers, including certain medications. This study aimed to evaluate the impact of beta-blockers as triggers for drug-induced lichen planus in hypertensive patients.
Keywords
Beta-Blockers, Lichen Planus, Hypertension, Drug-Induced
Beta-Blockers articles, Lichen Planus articles, Hypertension articles, Drug-Induced articles.
Article Details
Introduction